Vascular endothelial growth factor, wild-type p53, and angiogenesis in early operable non-small cell lung cancer

Clinical Cancer Research

Volumn 4, Issue 12, 1998, Pages 3017-3024

  Giatromanolaki, Alexandra ^a   Koukourakis, Michael I ^a   Kakolyris, Stylianos ^a   Turley, Helen ^b   O'Byrne, Ken ^c   Scott, Prudence A E ^b   Pezzella, Francesco ^b   Georgoulias, Yassilios ^a   Harris, Adrian L ^b   Gatter, Kevin C ^b,d  

^a UNIVERSITY HOSPITAL OF IRAKLION   (Greece)

^b OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^c LEICESTER ROYAL INFIRMARY   (United Kingdom)

^d JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER GRADING; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION; GROWTH INHIBITION; HUMAN; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION; TUMOR SUPPRESSOR GENE; TUMOR VASCULARIZATION;

AGED; ANTIBODIES, MONOCLONAL; CARCINOMA, NON-SMALL-CELL LUNG; CELL DIFFERENTIATION; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG; LUNG NEOPLASMS; LYMPHOKINES; MALE; MIDDLE AGED; MITOTIC INDEX; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 17444378271     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Vincenti, V., Cassano, C., Rocchi, M., and Persico, G. Assignment of the vascular endothelial growth factor gene to the human chromosome 6p21.3. Circulation, 93: 1493-1495, 1996.
2. Tischer, E., Mitchell, R., Hartman, T., Silva, M., Gospodarowicz, D., Fidders, J. C., and Abraham, J. A. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J. Biol. Chem., 260: 11947-11954, 1991.
3. Ferrara, N., and Davis-Smyth, T. The biology of vascular endothelial growth factor. Endocr. Rev., 18: 4-25, 1997.
4. Vermeulen, P. B., Gasparini, G., Fox, S. B., Toi, M., Martin, L., McCulloch, P., Pezzella, F., Viale, G., Weidner, N., Harris, A. L., and Dirix, L. Y. Quantification of angiogenesis in solid tumors: an international consensus on the methodology and criteria of evaluation. Eur. J. Cancer, 14: 2474-2484, 1996.
5. Folkman, J., and Klagsbrun, M. Angiogenic factors. Science (Washington DC), 235: 442-447, 1987.
6. Clauss, M., Gerlach, M., Gerlach, H., Brett, J., Wang, F., Familletti, P. C., Pan, Y. C., Olander, J. V., Connolly, D. T., and Stern, D. Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J. Exp. Med., 772: 1535-1545, 1990.
7. Toi, M., Inada, K., Suzuki, H., and Tominaga, T. Tumor angiogenesis in breast cancer: its importance as a prognostic indicator and the association with vascular endothelial growth factor expression. Breast Cancer Res. Treat., 36: 193-204, 1995.
8. Takahashi, Y., Kitadai, Y., Bucana, C. D., Cleary, K. R., and Ellis, L. M. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res., 55: 3964-3968, 1995.
9. Maeda, K., Chung, Y. S., Ogawa, Y., Takatsuka, S., Kang, S. M., Ogawa, M., Sawada, T., and Sowa, M. Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer (Phila.), 77: 858-863, 1996.
10. O'Brien, T., Cranston, D., Fuggle, S., Bicknell, R., and Harris, A. L. Different angiogenic pathways characterize superficial and invasive bladder cancer. Cancer Res., 55: 510-513, 1995.
11. Zhang, L., Scott, P., Turley, H., Leek, R., Lewis, C. E., Garter, K. C., Harris, A. L., Mackenzie, I. Z., Rees, M. P., and Bicknell, R. Validation of anti-vascular endothelial growth factor (anti-VEGF) antibodies for immunohistochemical localization of VEGF in tissue sections: expression of VEGF in the human endometrium. J. Pathol., 185: 402-408, 1998.
12. Giatromanolaki, A., Koukourakis, M., O'Byme, K., Fox, S., Whitehouse, R., Talbot, D., Harris, A. L., and Gatter, K. C. Angiogenesis is a significant prognostic marker in operable non small cell lung cancer. J. Pathol., 179: 80-88, 1996.